Development of a research agenda for percutaneous renal tumor ablation: Proceedings from a multidisciplinary research consensus panel

Journal of Vascular and Interventional Radiology

Volumn 21, Issue 12, 2010, Pages 1807-1816

  Georgiades, Christos S ^a   Rodriguez, Ronald ^a   Littrup, Peter J ^d   Frangakis, Constantine E ^c   Leveille, Raymond ^e   Ahrar, Kamran ^f   Atwell, Thomas D ^h   Cadeddu, Jeffrey ^g   Trimmer, Clayton ^g   Durack, Jeremy C ⁱ   Hammers, Hans Joerg ^b   Meng, Maxwell V ⁱ   Raman, Steven ^j   Solomon, Stephen B ^k   Zagoria, Ronald J ^l   McLennan, Gordon ^m   Laberge, Jeanne M ⁱ   Gervais, Debra A ⁿ   Kee, Stephen T ^j  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF TEXAS   (United States)

^g UNIVERSITY OF TEXAS AT DALLAS   (United States)

^h MAYO CLINIC   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^l WAKE FOREST SCHOOL OF MEDICINE   (United States)

^m LERNER RESEARCH INSTITUTE   (United States)

ⁿ MASSACHUSETTS GENERAL HOSPITAL   (United States)

more..

Author keywords

Abbreviations; H E; Hematoxylin and eosin; NADH; Nicotinamide adenine dinucleotide; Radiofrequency; RCC; RCP; Renal cell carcinoma; Research consensus panel; RF; SIR; Society of Interventional Radiology

Indexed keywords

CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CRYOABLATION; HUMAN; INTERMETHOD COMPARISON; KIDNEY CARCINOMA; METASTASIS; MICROWAVE THERAPY; NEPHRON SPARING SURGERY; NOTE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SYSTEMIC THERAPY; TUMOR ABLATION;

ANIMALS; CARCINOMA, RENAL CELL; CATHETER ABLATION; COOPERATIVE BEHAVIOR; EVIDENCE-BASED MEDICINE; HUMANS; INTERNATIONAL COOPERATION; KIDNEY NEOPLASMS; RESEARCH DESIGN; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TRANSLATIONAL RESEARCH; TREATMENT OUTCOME;

EID: 78649511987     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2010.10.002     Document Type: Note

References (70)

1. F. Becker, S. Siemer, U. Humke, M. Hack, M. Ziegler, and M. Stockle Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: long-term survival data of 216 patients Eur Urol 49 2006 308 313
2. V. Ficarra, A. Galfano, and M. Mancini TNM staging systems for renal cell carcinoma: current status and future perspectives Lancet Oncol 8 2007 554 558
3. D.A. Kunkle, and R.G. Uzzo Cryoablation or radiofrequency ablation of the small renal mass: a meta-analysis Cancer 113 2008 2671 2680
4. M.J. Horner, L.A.G. Ries, and M. Krapcho SEER cancer statistics review 19752006 National Cancer Institute Bethesda, MD
5. J. Hafron, and J.H. Kaouk Cryosurgical ablation of renal cell carcinoma Cancer Control 14 2007 211 217
6. M.A. Kuczyk, A.G. Anastasiades, and R. Zimmermann Current aspects of the surgical management of organ-confined, metastatic and recurrent renal cell cancer BJU Int 96 2005 721 727
7. S. Ozono, N. Miyao, and T. Igarashi Tumor doubling time of renal cell carcinoma measured by CT: collaboration of Japanese Society of Renal Cancer Jpn J Clin Oncol 34 2004 82 85
8. L. Lipworth, R.E. Tarone, and J.K. McLaughlin The epidemiology of renal cell carcinoma J Urol 176 2006 2353 2358
9. L.G. Luciani, R. Cestari, and C. Tallarigo Incidental renal cell carcinoma-age and stage characterization and clinical implications: study of 1092 patients (19821997) Urology 56 2000 58 62
10. A.J. Pantuck, A. Zisman, M.K. Rauch, and A. Belldegrun Incidental renal tumors Urology 56 2000 190 196
11. W.Y. Siow, S.K. Yip, L.G. Ng, P.H. Tan, W.S. Cheng, and K.T. Foo Renal cell carcinoma: incidental detection and pathological staging J R Coll Surg Edinb 45 2000 291 295
12. A.F. Fergany, K.S. Hafez, and A.C. Novick Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year follow up J Urol 163 2000 442 445
13. S.C. Campbell, A.C. Novick, and A. Belldegrun Guidelines for the management of the clinical stage T1 renal mass J Urol 182 2009 1271 1279
14. D.C. Miller, J.M. Hollingsworth, K.S. Hafez, S. Daignault, and B.K. Hollenbeck Partial nephrectomy for small renal masses: an emerging quality of care concern? J Urol 175 2006 853 857
15. S. Naito, N. Yamamoto, and T. Takayama Prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era: a cooperative group report of 1463 patients Eur Urol 57 2010 317 325
16. H.S. Hofmann, H. Neef, K. Krohe, P. Andreev, and R.E. Silber Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma Eur Urol 48 2005 77 81
17. P. Russo, and M.F. O'Brien Surgical intervention in patients with metastatic renal cancer: Metastasectomy and cytoreductive nephrectomy Urol Clin North Am 35 2008 679 686
18. S.E. Eggener, O. Yossepowitch, S. Kundu, R.J. Motzer, and P. Russo Risk score and metastasectomy independently impact prognosis in patients with recurrent renal cell carcinoma J Urol 180 2008 873 878
19. M. Carballo, M.S. Maish, D.E. Jaroszewski, and C.E. Holmes Video-assisted thoracic surgery (VATS) as a safe alternative for the resection of pulmonary metastases: a retrospective cohort study J Cardiothorac Surg 4 2009 13 24
20. R.J. Motzer, T.E. Hutson, and P. Tomczak Sunitinib versus interferon alfa in metastatic renal-cell carcinoma N Engl J Med 356 2007 115 124
21. M.A. Farrell, W.J. Charboneau, and D.S. DiMarco Image-guided radiofrequency ablation of solid renal tumors AJR Am J Roentgenol 180 2003 1509 1513
22. D.A. Gervais, F.J. McGovern, R.S. Arellano, W.S. McDougal, and P.R. Mueller Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors AJR Am J Roentgenol 185 2005 64 71
23. N.J. Hegarty, I.S. Gill, and M.M. Desai Probe-ablative nephron-sparing surgery: cryoablation versus radiofrequency ablation Urology 68 1 Suppl 2006 7 13
24. R.J. Zagoria, M.A. Traver, and D.M. Werle Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas AJR Am J Roentgenol 189 2007 429 436
25. A. Gupta, J.D. Raman, and R.J. Leveillee General anesthesia and contrast-enhanced computed tomography to optimize renal percutaneous radiofrequency ablation: multi-institutional intermediate-term results J Endourol 23 2009 1099 1105
26. I.M. Varkarakis, M.E. Allaf, and T. Inagaki Percutaneous radio frequency ablation of renal masses: results at a 2-year mean followup J Urol 174 2005 456 460
27. A.W. Levinson, L.M. Su, and D. Agarwal Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass J Urol 180 2008 499 504
28. I.S. Gill, E.M. Remer, and W.A. Hasan Renal cryoablation: outcome at 3 years J Urol 173 2005 1903 1907
29. R.J. Stein, and J.H. Kaouk Renal cryotherapy: a detailed review including a 5-year follow-up BJU Int 99 2007 1265 1270
30. P.J. Littrup, A. Ahmed, and H.D. Aoun CT-guided percutaneous cryotherapy of renal masses J Vasc Interv Radiol 18 2007 383 392
31. T.D. Atwell, M.A. Farrell, and B.C. Leibovich Percutaneous renal cryoablation: experience treating 115 tumors J Urol 179 2008 2136 2140
32. D.J. Breen, E.E. Rutherford, and B. Stedman Management of renal tumors by image-guided radiofrequency ablation: experience in 105 tumors Cardiovasc Intervent Radiol 30 2007 936 942
33. P.E. Clark, R.D. Woodruff, R.J. Zagoria, and M.C. Hall Microwave ablation of renal parenchymal tumors before nephrectomy: phase I study AJR Am J Roentgenol 188 2007 1212 1214
34. D.A. Gervais, F.J. McGovern, and B.J. Wood Radio-frequency ablation of renal cell carcinoma: early clinical experience Radiology 217 2000 665 672
35. D.A. Gervais, F.J. McGovern, R.S. Arellano, W.S. McDougal, and P.R. Mueller Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors Radiology 226 2003 417 424
36. S. Kawamoto, S.B. Solomon, D.A. Bluemke, and E.K. Fishman Computed tomography and magnetic resonance imaging appearance of renal neoplasms after radiofrequency ablation and cryoablation Semin Ultrasound CT MR 30 2009 67 77
37. E. Squillaci, G. Manenti, and C. Ciccio Perfusion-CT monitoring of cryo-ablated renal cells tumors J Exp Clin Cancer Res 28 2009 138 149
38. M.F. Meloni, M. Bertolotto, and C. Alberzoni Follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: contrast-enhanced sonography versus contrast-enhanced CT or MRI AJR Am J Roentgenol 191 2008 1233 1238
39. S.V. Setola, O. Catalano, F. Sandomenico, and A. Siani Contrast-enhanced sonography of the kidney Abdom Imaging 32 2007 21 28
40. S.N. Goldberg, G.S. Gazelle, C.C. Compton, P.R. Mueller, and K.K. Tanabe Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation Cancer 88 2000 2452 2463
41. D.A. Gervais, R.S. Arellano, F.J. McGovern, W.S. McDougal, and P.R. Mueller Radiofrequency ablation of renal cell carcinoma: part 2, Lessons learned with ablation of 100 tumors AJR Am J Roentgenol 185 2005 72 80
42. E.M. Merkle, S.G. Nour, and J.S. Lewin MR imaging follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: findings in 18 patients during first 6 months Radiology 235 2005 1065 1071
43. E.D. Matsumoto, L. Watumull, and D.B. Johnson The radiographic evolution of radiofrequency ablated renal tumors J Urol 172 2004 45 48
44. S. Javadi, S.F. Matin, P. Tamboli, and K. Ahrar Unexpected atypical findings on CT after radiofrequency ablation for small renal-cell carcinoma and the role of percutaneous biopsy J Vasc Interv Radiol 18 2007 1186 1191
45. R.A. Rendon, J.R. Kachura, and J.M. Sweet The uncertainty of radio frequency treatment of renal cell carcinoma: findings at immediate and delayed nephrectomy J Urol 167 2002 1587 1592
46. C.J. Weight, J.H. Kaouk, and N.J. Hegarty Correlation of radiographic imaging and histopathology following cryoablation and radio frequency ablation for renal tumors J Urol 179 2008 1277 1281
47. S. Mylona, S. Ntai, and E. Stroumbouli Renal cell carcinoma radiofrequency ablation: Evaluation of efficacy based on histological correlation Br J Radiol 81 2008 479 484
48. S.F. Matin, K. Ahrar, and J.A. Cadeddu Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study J Urol 176 2006 1973 1977
49. K. Ahrar, S. Matin, and C.G. Wood Percutaneous radiofrequency ablation of renal tumors: technique, complications, and outcomes J Vasc Interv Radiol 16 2005 679 688
50. M. Aron, K. Kamoi, and E. Remer Laparoscopic renal cryoablation: 8-year, single surgeon outcomes J Urol 183 2010 889 895
51. T.D. Atwell, M.A. Farrell, and M.R. Callstrom Percutaneous cryoablation of 40 solid renal tumors with US guidance and CT monitoring: initial experience Radiology 243 2007 276 283
52. S. Park, J.K. Anderson, and E.D. Matsumoto Radiofrequency ablation of renal tumors: intermediate-term results J Endourol 20 2006 569 573
53. A.J. Stein, J.M. Mayes, and V. Mouraviev Persistent contrast enhancement several months after laparoscopic cryoablation of the small renal mass may not indicate recurrent tumor J Endourol 22 2008 2433 2439
54. S. Javadi, J.U. Ahrar, and E. Ninan Characterization of contrast enhancement in the ablation zone immediately after radiofrequency ablation of renal tumors J Vasc Interv Radiol 21 2010 690 695
55. B.R. Matlaga, R.J. Zagoria, R.D. Woodruff, F.M. Torti, and M.C. Hall Phase II trial of radio frequency ablation of renal cancer: evaluation of the kill zone J Urol 168 2002 2401 2405
56. V. Margulis, E.D. Matsumoto, and G. Lindberg Acute histologic effects of temperature-based radiofrequency ablation on renal tumor pathologic interpretation Urology 64 2004 660 663
57. J.D. Raman, J.M. Stern, I. Zeltser, W. Kabbani, and J.A. Cadeddu Absence of viable renal carcinoma in biopsies performed more than 1 year following radio frequency ablation confirms reliability of axial imaging J Urol 179 2008 2142 2145
58. M.S. Davenport, E.M. Caoili, and R.H. Cohan MRI and CT characteristics of successfully ablated renal masses: imaging surveillance after radiofrequency ablation AJR Am J Roentgenol 192 2009 1571 1578
59. M.J. Michaels, H.K. Rhee, and A.P. Mourtzinos Incomplete renal tumor destruction using radio frequency interstitial ablation J Urol 168 2002 2406 2409
60. J.K. Anderson, M. Baker, and O. Jaffers Time course of nicotinamide adenine dinucleotide diaphorase staining after renal radiofrequency ablation influences viability assessment J Endourol 21 2007 223 227
61. J.M. Stern, J.K. Anderson, Y. Lotan, S. Park, and J.A. Cadeddu Nicotinamide adenine dinucleotide staining immediately following radio frequency ablation of renal tumors-is a positive stain synonymous with ablative failure? J Urol 176 2006 1969 1972
62. A. Sidana, W.H. Chowdhury, E.J. Fuchs, and R. Rodriguez Cryoimmunotherapy in urologic oncology Urology 75 2010 1009 1014
63. M.H. den Brok, R.P. Sutmuller, and S. Nierkens Synergy between in situ cryoablation and TLR9 stimulation results in a highly effective in vivo dendritic cell vaccine Cancer Res 66 2006 7285 7292
64. S. Nierkens, M.H. den Brok, and T. Roelofsen Route of administration of the TLR9 agonist CpG critically determines the efficacy of cancer immunotherapy in mice PLoS One 4 2009 e8368
65. A. Machlenkin, O. Goldberger, and B. Tirosh Combined dendritic cell cryotherapy of tumor induces systemic antimetastatic immunity Clin Cancer Res 11 2005 4955 4961
66. M.Y. Levy, A. Sidana, and W.H. Chowdhury Cyclophosphamide unmasks an antimetastatic effect of local tumor cryoablation J Pharmacol Exp Ther 330 2009 596 601
67. R.E. Glicklich, N.A. Dreyer, Registries for evaluating patient outcomes: a user's guide (Prepared by outcome DEcIDE center [Outcome Sciences; dba Outcome] under Contract No. HHSA29020050035IT01.) AHRQ Publication No. 07-EHC001-1. April 2007 2007 Agency for Healthcare Research and Quality Rockville, MD
68. J. Concato, N. Shah, and R.I. Horwitz Randomized, controlled trials, observational studies, and the hierarchy of research designs N Engl J Med 22 2000 1887 1892 342
69. C.M. Clancy, and J.M. Eisenberg Outcomes research: measure the end results of health care Science 282 1998 245 246
70. S.N. Goldberg, C.J. Grassi, and J.F. Cardella Image-guided tumor ablation: standardization of terminology and reporting criteria Radiology 235 2005 728 739